Schedule 13G ownership disclosure
Spyre Therapeutics Inc
Security class unavailable · CUSIP: 00773J202
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.9630%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-24-001784
- Form type
- SC 13G
- Filer
- FMR LLC
- CIK
- CIK 315066
- Filed
- Jun 10, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership